Which Antibiotics Are Commonly Used for a Sinus Infection?

When a sinus infection may need antibiotics

The vast majority of rhinosinusitis cases are caused by viruses, and antibiotics have no effect on viral illnesses. The Centers for Disease Control and Prevention estimates that 90 to 98 percent of acute rhinosinusitis cases fall into this viral category. Using antibiotics for these infections does not speed recovery, relieve symptoms, or prevent complications, while still exposing the patient to potential side effects and contributing to broader public health concerns.

Because bacterial infections are relatively uncommon in the initial presentation of sinus symptoms, clinicians rely on specific symptom patterns to identify cases where antibiotics may be appropriate. Acute bacterial rhinosinusitis in adults is typically suspected when symptoms follow one of three clinical patterns. The first is persistence, where symptoms last for more than 10 days without any sign of improvement. The second is severity, characterized by high fever, facial pain, and purulent nasal discharge that are intense from the onset and last for at least three to four consecutive days. The third pattern is worsening, often described as a “double sickening” phase, where a patient initially appears to be recovering from a common cold but then experiences a return or significant escalation of symptoms, such as fever or nasal discharge, after the initial viral phase.

A common misconception is that the color of nasal mucus alone indicates a bacterial infection. Thick, yellow, or green discharge is a normal part of the immune response in both viral and bacterial sinusitis and is not a reliable standalone indicator for prescribing antibiotics. Clinical diagnosis depends on the duration, severity, and progression of symptoms rather than mucus appearance.

For patients who present with uncomplicated symptoms but do not meet the strict criteria for immediate antibiotic therapy, watchful waiting is an accepted management option. This approach allows the body to clear the viral infection naturally while the patient uses supportive care to manage discomfort. This strategy is only appropriate when the patient has reliable follow-up access, ensuring that care can be escalated if symptoms worsen or fail to resolve within the expected timeframe.

Common first-line antibiotics for bacterial sinusitis

When clinical evaluation confirms or strongly suggests acute bacterial rhinosinusitis, antibiotic therapy is considered. For adults, the primary guideline-supported options for first-line therapy are amoxicillin or amoxicillin-clavulanate. These agents are widely used because they effectively target the most common bacterial pathogens responsible for sinus infections, including Streptococcus pneumoniae and Haemophilus influenzae.

Amoxicillin-clavulanate combines the antibiotic amoxicillin with clavulanic acid, a compound that inhibits beta-lactamase enzymes produced by certain bacteria. This combination prevents bacteria from breaking down the amoxicillin, thereby extending its effectiveness against resistant strains. While some clinical guidelines, such as those from the Infectious Diseases Society of America, prefer amoxicillin-clavulanate over amoxicillin alone for empiric treatment due to this broader spectrum, the choice between the two is not universal. Both remain standard first-line options, and the specific selection depends on local resistance patterns, patient history, and clinical judgment.

No single antibiotic is universally best for every patient. The decision to use amoxicillin versus amoxicillin-clavulanate, or to select a different class entirely, depends on multiple factors. These include the patient's allergy history, kidney and liver function, other medications they may be taking, prior antibiotic exposure, and the severity of the illness. Prescribers determine the appropriate dose and duration based on these individual clinical factors rather than applying a one-size-fits-all protocol. While amoxicillin-based regimens form the backbone of initial treatment, the precise medication and dosage are tailored to the individual's medical profile.

Alternatives for penicillin allergy or other clinical concerns

Patients with a documented allergy to penicillin or those who cannot tolerate amoxicillin-based regimens require alternative antibiotic strategies. The specific alternative chosen depends heavily on the nature of the allergy and other clinical considerations.

For adults, doxycycline is a recognized alternative regimen for acute bacterial rhinosinusitis. It is often selected for patients with penicillin allergies who are not candidates for beta-lactam antibiotics. Doxycycline provides effective coverage against common sinus pathogens and is suitable for adults, though it is generally not recommended for children due to risks affecting tooth and bone development.

In cases where doxycycline is unsuitable or ineffective, respiratory fluoroquinolones such as levofloxacin or moxifloxacin serve as another alternative option. These agents are potent broad-spectrum antibiotics that can be effective in treating sinus infections resistant to first-line therapies. Their use is typically reserved for specific clinical scenarios due to safety profiles and resistance concerns, which are detailed in the section on reserved antibiotics.

The selection of an alternative is rarely straightforward. Factors such as age, pregnancy status, renal or hepatic impairment, interacting medications, prior antibiotic use, illness severity, and local bacterial resistance rates all influence the final decision. A reported penicillin allergy does not automatically preclude the use of all beta-lactam antibiotics. In some cases, cephalosporins may be considered safe even in patients with a penicillin allergy, depending on the type of previous reaction. This determination requires careful evaluation by a clinician who can assess the risk profile accurately. The choice of alternative therapy is a nuanced clinical decision based on a comprehensive review of the patient's medical history and current condition.

Antibiotics that are usually avoided or reserved

Not all antibiotics are appropriate for the routine empiric treatment of acute bacterial sinusitis. Certain classes of drugs are either discouraged or strictly reserved due to lack of efficacy, high resistance rates, or significant safety concerns.

Macrolide antibiotics, such as azithromycin (often known as a Z-Pak) and clarithromycin, are not recommended for empiric treatment of acute bacterial rhinosinusitis under current US guidance. This recommendation is primarily due to high rates of resistance among Streptococcus pneumoniae, the most common cause of bacterial sinus infections. Azithromycin and other macrolides often fail to eradicate the infection, leading to prolonged illness and potential complications without providing clinical benefit.

Respiratory fluoroquinolones, including levofloxacin and moxifloxacin, are effective against sinus pathogens but are subject to strict usage guidelines. The FDA advises reserving systemic fluoroquinolones for acute bacterial sinusitis only when no other treatment options are available. This restriction is due to the risk of disabling and potentially permanent serious adverse effects, such as tendon rupture, nerve damage, and central nervous system disturbances. In the context of acute bacterial sinusitis, which is often self-limiting or manageable with safer alternatives, the potential benefits of fluoroquinolones are often outweighed by these significant risks.

Older antibiotics like trimethoprim-sulfamethoxazole are not recommended as standard empiric care for acute bacterial rhinosinusitis due to high rates of pneumococcal resistance. Topical or compounded antibiotic preparations are also not considered standard empiric treatments and lack sufficient evidence to support their routine use. The goal of antibiotic selection is to use the safest, most effective agent that minimizes resistance and adverse events, which currently points away from these reserved or avoided options.

What to expect after starting treatment

Patients starting antibiotic therapy for acute bacterial sinusitis should have realistic expectations regarding recovery. Improvement is typically assessed over the first several days of treatment. While antibiotics work to reduce bacterial load, they do not immediately resolve all symptoms. Nasal congestion, facial pressure, and postnasal drip may persist for days or even weeks after the infection is cleared, as inflammation takes longer to subside. It is common for symptoms to fluctuate during the recovery period.

A clear clinical trajectory should be observable. If symptoms worsen after 48 to 72 hours of starting an antibiotic, or if there is no improvement after 3 to 5 days, this signals a need for clinician reassessment. This timeframe is based on IDSA guideline recommendations for managing treatment failure. Patients should not attempt to self-direct treatment by switching antibiotics, increasing doses, or extending the duration of their prescription without medical consultation.

When a patient does not improve within these windows, clinicians consider several possible reasons for treatment failure. These may include infection with a resistant organism that is not covered by the prescribed antibiotic, a noninfectious cause of symptoms such as allergies or migraines, an underlying structural abnormality like a deviated septum or nasal polyp, or an incorrect initial diagnosis. Identifying the correct cause of nonresponse is essential for determining the next steps in management, which may include changing the antibiotic, adding supportive therapies, or pursuing further diagnostic evaluation.

Side effects, antibiotic resistance, and safe use

Antibiotics are powerful medications that carry inherent risks, both for the individual and for public health. One of the primary concerns with antibiotic use is the development of antimicrobial resistance. When antibiotics are used unnecessarily, particularly for viral sinusitis where they are ineffective, bacteria have the opportunity to adapt and develop mechanisms to survive the drug. This reduces the effectiveness of antibiotics for future infections, making them harder to treat and increasing the risk of complications.

Antibiotic use can also cause adverse effects in the patient. These range from mild gastrointestinal issues, such as nausea and diarrhea, to more serious conditions like Clostridioides difficile infection or severe allergic reactions. While the risk of side effects varies by drug, all antibiotics carry some potential for harm. Antibiotics should be used only when clearly indicated, specifically for confirmed or strongly suspected bacterial infections, and never for viral illnesses.

To minimize risks, patients must use antibiotics exactly as prescribed by their clinician. This includes taking the correct dose at the prescribed intervals and completing the full course of therapy as directed, unless instructed otherwise by a healthcare provider. Sharing antibiotics with others or saving leftover medication for future use is dangerous and contributes to resistance. Future illnesses may be caused by different pathogens or may be viral, rendering the leftover medication ineffective or inappropriate. Safe use of antibiotics relies on adherence to medical advice and avoiding self-directed treatment decisions.

When to seek urgent care or further evaluation

Most cases of acute bacterial sinusitis can be managed as an outpatient, but certain symptoms indicate potential complications that require immediate medical attention. Distinguishing between routine recovery symptoms and signs of serious complications is critical.

Urgent clinical evaluation is necessary if symptoms suggest the spread of infection to adjacent structures, such as the eyes or brain. Warning signs of orbital or intracranial complications include periorbital swelling (swelling around the eye), vision changes or impairment, severe headache that does not respond to usual treatments, altered mental status, confusion, or meningeal signs such as neck stiffness. These symptoms can indicate serious conditions like orbital cellulitis, meningitis, or brain abscess, which are medical emergencies requiring prompt intervention.

In addition to acute complications, patients with recurrent or chronic sinus symptoms should seek evaluation for underlying causes. Repeated episodes of sinusitis or persistent symptoms lasting beyond the typical acute phase may indicate chronic sinusitis, nasal polyps, immune deficiencies, or other structural issues. These conditions require different management strategies and are not adequately treated by repeated courses of antibiotics alone. A clinician can assess the need for further diagnostic testing, such as imaging or endoscopy, and develop a long-term management plan tailored to the specific underlying condition.